Diabetes and restenosis

Cardiovasc Diabetol. 2022 Feb 14;21(1):23. doi: 10.1186/s12933-022-01460-5.


Restenosis, defined as the re-narrowing of an arterial lumen after revascularization, represents an increasingly important issue in clinical practice. Indeed, as the number of stent placements has risen to an estimate that exceeds 3 million annually worldwide, revascularization procedures have become much more common. Several investigators have demonstrated that vessels in patients with diabetes mellitus have an increased risk restenosis. Here we present a systematic overview of the effects of diabetes on in-stent restenosis. Current classification and updated epidemiology of restenosis are discussed, alongside the main mechanisms underlying the pathophysiology of this event. Then, we summarize the clinical presentation of restenosis, emphasizing the importance of glycemic control in diabetic patients. Indeed, in diabetic patients who underwent revascularization procedures a proper glycemic control remains imperative.

Keywords: ACS; BMS; CABG; DES; Diabetes; Endothelial dysfunction; Epidemiology; Hyperglycemia; PCI; Restenosis; STEMI; Stent; VSMC.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angioplasty, Balloon, Coronary* / adverse effects
  • Coronary Angiography / adverse effects
  • Coronary Restenosis* / epidemiology
  • Coronary Restenosis* / etiology
  • Diabetes Mellitus* / diagnosis
  • Diabetes Mellitus* / epidemiology
  • Diabetes Mellitus* / etiology
  • Humans
  • Stents / adverse effects
  • Treatment Outcome